Next-Gen Gene Editing Corrects Root Cause of Severe Epilepsy in Mice

Scientists at the University of Virginia School of Medicine have utilized a next-generation gene-editing technique to address the underlying cause of a severe form of epilepsy in laboratory mice. This method, known as base editing, corrected the gene mutation responsible for SCN8A developmental and epileptic encephalopathy (DEE).

Understanding SCN8A DEE: A Severe Inherited Epilepsy

SCN8A DEE is an inherited epilepsy estimated to affect 1 in 56,000 births. It results from a mutation in the SCN8A gene, which leads to excessive sodium flow into brain neurons, causing hyperexcitability and seizures.

The condition often presents in early infancy, causing seizures, learning disabilities, movement problems, and carries a risk of sudden unexpected death in epilepsy (SUDEP).

The Precision of Base Editing

Researchers, led by Dr. Manoj Patel, applied base editing to target and correct the single nucleotide mutation in the SCN8A gene. This precise form of gene editing minimizes unwanted side effects.

In the lab mice, the intervention eliminated or significantly reduced seizures, increased overall survival, improved movement abilities, and decreased anxiety-like behaviors.

Promising Results and Reversibility

Analysis of the mice's brains indicated a reduction in sodium flow into neurons and decreased neuronal hyperexcitability, confirming the desired effect of the gene correction.

The research team noted that the study demonstrates the reversibility of the mutation's impact.

Future Outlook and Broader Implications

While further research is necessary before human application, the findings suggest a potential path for treating SCN8A-related epilepsy and other inherited epilepsies.

The work underscores the broader potential of base-editing technology for genetic diseases. The goal is to assess this gene therapy in children with the specific SCN8A variant.

The findings were published in the Journal of Clinical Investigation.